Search research articles
Contact Us
Filters
Showing results (681-690 of 831) with videos related to
Page
of 84
Sort By:
Neuro-Oncology
|
February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Timothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Neuro-Oncology
|
May 25, 2007
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model
Thomas-Toan Tran, Martin Uhl, Jing Ying Ma, et al.
Neuro-Oncology
|
May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Michael Lim, Michael Weller, Ahmed Idbaih, et al.
Acta Neuropathologica
|
January 18, 2012
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial
Monika E Hegi, Robert-Charles Janzer, Wanyu L Lambiv, et al.
Neuro-Oncology
|
August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Neuro-Oncology
|
April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective
Benedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Cancer Cell
|
March 26, 2019
Evolutionary Trajectories of IDH<sup>WT</sup> Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Verena Körber, Jing Yang, Pankaj Barah, et al.
The Lancet. Oncology
|
August 18, 2018
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
Martin J van den Bent, Martin Klein, Marion Smits, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Nature Reviews. Clinical Oncology
|
December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Page
of 84
Search research articles
Search
Showing results (681-690 of 831) with videos related to
Sort By:
Page
of 84
Neuro-Oncology
|
February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Timothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Neuro-Oncology
|
May 25, 2007
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model
Thomas-Toan Tran, Martin Uhl, Jing Ying Ma, et al.
Neuro-Oncology
|
May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Michael Lim, Michael Weller, Ahmed Idbaih, et al.
Acta Neuropathologica
|
January 18, 2012
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial
Monika E Hegi, Robert-Charles Janzer, Wanyu L Lambiv, et al.
Neuro-Oncology
|
August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Neuro-Oncology
|
April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective
Benedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Cancer Cell
|
March 26, 2019
Evolutionary Trajectories of IDH<sup>WT</sup> Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Verena Körber, Jing Yang, Pankaj Barah, et al.
The Lancet. Oncology
|
August 18, 2018
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
Martin J van den Bent, Martin Klein, Marion Smits, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Nature Reviews. Clinical Oncology
|
December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Page
of 84